Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Dose Radiotherapy vs Ibandronate for Metastatic Bone Pain
NCT00082927Phase 3Completed
- Sponsor
- Cancer Research UK
- Start
- Apr 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ibandronate in bone metastases (2 arms), sponsored by Cancer Research UK. Primary endpoint: Pain response at 12 weeks. Started Apr 2003; status: completed.
02
Drugs
ibandronate
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT00082927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00082927.